EH
AGN

Equitable Holdings’s Allergan plc AGN Stock Holding History

Equitable Holdings’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,526
Closed -$2.04M – 661
2020
Q1 		$2.04M Sell
11,526
-26,336
-70% -$4.96M 0.07% 161
2019
Q4 		$7.24M Buy
+37,862
New +$6.83M 0.21% 82

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Equitable Holdings's AGN Position: Q2 2020 in Review

Equitable Holdings sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 11,526 shares — an estimated $2.04M sold.

Equitable Holdings first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $7.24M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Equitable Holdings reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Equitable Holdings sold 11,526 Allergan plc shares in Q2 2020, an estimated $2.04M.
  • Equitable Holdings first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Equitable Holdings's Allergan plc position peaked at $7.24M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Equitable Holdings's 13F filing for Q2 2020, filed 13 Aug 2020.